Meet Brian Chapin, M.D.
Brian F. Chapin, MD
Department of Urology, Division of Surgery
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Fellowship Program Director, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2004 | Georgetown University School of Medicine, Washington, DC, USA, MD, Medicine |
| 2000 | Siena College, Loudonville, NY, USA, BS, Biology |
Postgraduate Training
| 2010-2012 | Clinical Fellowship, Urologic Oncology, UT MD Anderson Cancer Center, Houston, TX |
| 2006-2009 | Clinical Residency, Urology, Massachusetts General Hospital, Boston, MA |
| 2005-2006 | Clinical Residency, General Surgery, Massachusetts General Hospital, Boston, MA |
| 2004-2005 | Clinical Internship, General Surgery, Massachusetts General Hospital, Boston, MA |
Board Certifications
| 2014 | American Board of Urology |
Experience & Service
Administrative Appointments/Responsibilities
Rotation Site Director, Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2013 - Present
Administrative Fellow, The University of Texas MD Anderson Cancer Center, Houston, TX, 2011 - 2011
Administrative Chief Resident, Massachusetts General Hospital, Boston, MA, 2008 - 2009
Administrative Chief Resident, Children's Hospital Boston, Boston, MA, 2008 - 2008
Honors & Awards
| 2011 | Best of Posters AUA/JUA: Post-operative Complications from Cytoreductive Nephrectomy after Pre-surgical Targeted Therapy for Metastatic Renal Cell Carcinoma, AUA |
| 2011 | Merit Award. Genitourinary Cancer Symposium (GU ASCO), American Society of Clinical Oncology |
| 2010 | American Urologic Association Foundation Research Scholarship, AUA |
| 2007 | Partners in Excellence Award, Massachusetts General Hospital |
| 2007 | Harvard Medical School Resident Teaching Award, Massachusetts General Hospital |
| 2004 | Cum Laude, Georgetown University School of Medicine |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Wirth GJ, Psutka SP, Chapin BF, Wu S, Wu CL, Dahl DM. Midterm Oncological Outcomes of Laparoscopic vs Open Radical Prostatectomy (RP). BJU Int 112(2):190-7, 2013. e-Pub 2013. PMID: 23601185.
- Chapin BF, Delacroix SE, Culp SH, Nogueras Gonzalez GM, Tannir NM, Jonasch E, Tamboli P, Wood CG. Safety of pre-surgical targeted therapy in the setting of metastatic renal cell carcinoma. Eur Urol 60(5):964-71, 2011. e-Pub 2011. PMID: 21621907.
- Cost NG, Delacroix SE, Sleeper JP, Smith PJ, Youssef RF, Chapin BF, Karam JA, Culp S, Abel EJ, Brugarolas J, Raj GV, Sagalowsky AI, Wood CG, Margulis V. The impact of targeted molecular therapies on the level of renal cell carcinoma venous tumor thrombus. Eur Urol 59(6):912-28, 2011. e-Pub 2011. PMID: 21367518.
- Eisner BH, Feldman AS, Chapin BF, Dretler SP. "Blind coning"--using the stone cone for removal of intramural ureteral calculi. Urology 69(4):773-75, 2007. PMID: 17445670.
- Oyelese Y, Tchabo JG, Chapin BF, Nair A, Hanson P, McLaren R. Conservative management of uterine rupture diagnosed prenatally on ultrasound. Ultrasound in Medicine 22:977-80, 2003. PMID: 14510271.
Invited Articles
- Delacroix SE, Chapin BF, Wood CG. The role of lymph node dissection in renal cell carcinoma. Urol Clin North Am 38(4):419-28, vi, 2011. PMID: 22045173.
- Chapin BF, Delacroix SE, Wood CG. Renal cell carcinoma; what the surgeon and treating physician need to know. AJR Am J Roentgenol 196(6):1255-62, 2011. PMID: 21606286.
- Chapin BF, Delacroix SE, Wood CG. The role of lymphadenectomy in renal cell carcinoma. International Journal of Clinical Oncology 16(3):186-94, 2011. e-Pub 2011. PMID: 21523561.
Editorials
- Chapin BF, Wood CG. The R.E.N.A.L. nephrometry nomogram: statistically significant, but is it clinically relevant?. Eur Urol 60(2):249-51, 2011. PMID: 21514040.
Abstracts
- Chapin, BF, Delacroix SE, et al. Can a Lymph node dissection alter outcomes in metastatic renal cell carcinoma?. American Urological Association Annual Meeting, 2012.
- Cost NG, Delacroix SE, Smith P, Youssef RF, Chapin BF, Karam J, Culp SH, Abel EJ, Rak GV, Sagalowsky AI, Wood CG, Margulis V. The impact of targeted molecular therapies on the level of renal cell carcinoma venous tumor thrombus. Society of Urologic Oncology. 2010, American Urologic Association, Orlando, Florida. 2011, ASCO 2011, J Clin Oncol 29: (suppl; abstr e15002), 2011.
- Delacroix SE, Chapin BF, Cost N, Karam JA, Culp S, Abel EJ, Gonzalez G, Margulis V, Wood CG. Can contemporary targeted therapies provide clinically meaningful changes in renal cell carcinoma venous tumor thrombi?. Genitourinary Cancers Symposium (GU ASCO) and American Urologic Association, 2011.
- Delacroix SE, Chapin BF, Cost N, Karam JA, Culp S, Abel EJ, Gonzalez G, Margulis V, Wood CG. Can contemporary targeted therapies provide clinically meaningful changes in renal cell carcinoma venous tumor thrombi?. Southeastern Sectional of the American Urologic Association, 2011.
- Chapin BF, Delacroix SE, Culp SH, Gonzalez G, Wood CG. Post operative complications from cytoreductive nephrectomy after neoadjuvant targeted therapy for metastatic renal cell carcinoma. Southeastern Sectional of the American Urologic Association, 2011.
- Chapin BF, Delacroix SE, Culp SH, Gonzalez G, Wood CG. Post operative complications from cytoreductive nephrectomy after pre-surgical targeted therapy for metastatic renal cell carcinoma. Genitourinary Cancer Symposium (GU ASCO), 2011.
- Chapin BF, Delacroix SE, Culp SH, Gonzalez G, Wood CG. Timing of cytoreductive nephrectomy does not influence survival in metastatic renal cell carcinoma. American Urologic Association Annual Meeting, 2011.
- Chapin BF, Delacroix SE, Culp SH, Gonzalez G, Wood CG. Post operative complications from cytoreductive nephrectomy after pre-surgical targeted therapy for metastatic renal cell carcinoma. American Urologic Association Annual Meeting, 2011.
- Chapin BF, Feldman AS, Psutka SP, Dahl DM. Predictors of post-prostatectomy incontinence: A multivariate analysis. New England Section of the American Urologic Association Annual Meeting, 2009.
- Chapin BF, Feldman AS, Dahl DM. Hydrodissection of the neurovascular bundles in laparoscopic radical prostatectomy: Impact on positive surgical margins. American Urological Association's National Meeting, 2009.
- Chapin BF, Eisner BH, Samir AM, Eswara JR, Hunter SE, Maher MM, Hahn PF, Gervais DA, McGovern FJ, McDougal WS, Mueller PR. Natural history of renal oncocytoma diagnosed by percutaneous biopsy. New England Section of the American Urologic Association, 2008.
- Eswara JR, Eisner BH, Chapin BF, McDougal WS. Long-term changes in renal function after radical and partial nephrectomy. 102nd Annual Meeting. American Urologic Association, 2007.
- Chapin BF, Eisner B, Lahey S, Tabatabaei S. KTP laser photovaporization of prostate in patients with large volume prostates. New England Section of the American Urologic Association, 2007.
Book Chapters
- Chapin BF, Delacroix SE, Wood CG. Cytoreductive Nephrectomy for Advanced Disease in Renal Cell Cancer: Principles and Practice. In: Kidney Cancer. Springer, 2012.